If what just happened in a California courtroom is a sign of things to come, executives from the agricultural company Monsanto (acquired recently by pharmaceutical giant Bayer) are sweating proverbial bullets.
There’s kind of a flip side -- both stark and dramatic -- to every stated upside concerning Bayer’s longtime industry-leading birth control implant Essure.
It took a jury eight hours to determine that damages of $550 million would fairly compensate 22 women plaintiffs for cancer-linked injuries they say they suffered from long-term use of Johnson & Johnson’s talcum powder.
Here’s a story with a California nexus that easily relates to residents in Connecticut and all other states.
No one can reasonably claim that a recent demand from the U.S. Food and Drug Administration aimed at makers of select baby teething products came unexpectedly.
Pelvic mesh implants were introduced about a generation ago. They have been widely used across the world to treat so-called “stress incontinence” in women.
On April 19, 2018, California resident Kevin Branca ("Plaintiff"), on behalf of himself and all others similarly situated, filed a putative class action against drink maker, Bai Brands LLC ("Defendant"), accusing the company of using misleading packaging that suggests its products are made with "all-natural" ingredients even though they are artificially flavored.
Executives with global colossus Johnson & Johnson are presently viewing talcum powder and other talc-based products in a manner sharply divergent from the elation that has long marked their preeminence as profit drivers for the company.
On January 16, 2018, Judge Ronald B. Leighton, of the United States District Court for the Western District of Washington, ruled that Ford Motor Company ("Ford") must face some of the claims in a proposed class action over allegedly defective sunroofs that can spontaneously shatter.
It is easy to note why furniture that one national news report states "can easily tip over" would spell a major concern for the company that makes it.